Published Thu, 06 Dec 2018 13:45:07 -0500 on Seeking Alpha
Tekla World Healthcare Fund (THW) is quite similar to another fund I just recently covered, Tekla Healthcare Opportunities Fund (THQ). Both funds focused on the healthcare sector. Actually, the four funds Tekla offers all cover healthcare related sectors. I believe THW is at a level offering an attractive yield, as well as not being overly priced for income investors, or possibly for an investor that would like more healthcare exposure in their portfolio. With THW's global emphasis, its holdings may provide just enough diversification for investors that are looking to international markets.
About The Fund
Taken from the THW Fact Sheet, they define this fund as "a non-diversified closed-end healthcare fund, THW employs a versatile growth and income investment strategy investing across all healthcare sub-sectors and across a company's full capital structure." This is almost the same exact phrasing as THQ. Similarly to THQ, this fund will investor in equities, preferred, or debt instruments within the healthcare sector, giving the fund a lot of flexibility in choosing what they believe is showing opportunity at the time. Where this fund differs from THQ is the additional line added in the description, "THW places an emphasis on innovative healthcare companies worldwide and invests at least 40% of managed assets in non-U.S. companies."
THW also employs the use of leverage and option writing to potentially enhance returns and income generation for... Read more
|Stock name||Last trade||P/E||Earnings/Share||Dividend/Share||Dividend yield|
|JOHNSON & JOHNSON||130.43||21.6||6.03||3.80||2.93|
Older articles featuring Johnson & Johnson (JNJ):Of 56 Kiplinger Outstanding Dividend Stocks, 11 Show Sweetness For December
Vanguard High Dividend Yield ETF: Rotation From Growth Into Value Stocks Should Boost Investor Appetite For This ETF
6 Wonderful Black Friday Dividend Aristocrat Deals
Dividend Stock Purchase: Lanny's October 2020 Summary
Dividend Growth Up To 18%: These Aristocrats Deliver During The Pandemic
Is Pfizer The Best COVID Vaccine Play For Dividend Investors?
Dividend Champion And Contender Highlights: Week Of November 15
47 Dividend Stocks For Our Changing Times: November Update
BMEZ: Solid Performance, Collecting A 4.67% Yield
ADX: Positive Returns, Looking Forward To A Year-End Special Dividend